Deletion of Histone Deacetylase 7 in Osteoclasts Decreases Bone Mass in Mice by Interactions with MITF

MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice

(2012) Ha-Neui Kim et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

HDAC7 Inhibits Osteoclastogenesis by Reversing RANKL-Triggered β-Catenin Switch

(2012) Zixue Jin et al.   MOLECULAR ENDOCRINOLOGY

Vitamin E decreases bone mass by stimulating osteoclast fusion

(2012) Koji Fujita et al.   NATURE MEDICINE

HDAC inhibitor trichostatin A suppresses osteoclastogenesis by upregulating the expression of C/EBP-β and MKP-1

(2011) Paul J. Williams et al.   Annals of the New York Academy of Sciences

Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts

(2011) Meghan E. McGee-Lawrence et al.   BONE

HDAC3 and HDAC7 Have Opposite Effects on Osteoclast Differentiation

(2011) Lan Pham et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases

(2011) Melissa D. Cantley et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Neuroprotection by Histone Deacetylase-7 (HDAC7) Occurs by Inhibition of c-junExpression through a Deacetylase-independent Mechanism

(2010) Chi Ma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Histone Deacetylase 7 and FoxA1 in Estrogen-Mediated Repression of RPRM

(2009) S. Malik et al.   MOLECULAR AND CELLULAR BIOLOGY

The Microphthalmia Transcription Factor Regulates Expression of the Tartrate-Resistant Acid Phosphatase Gene During Terminal Differentiation of Osteoclasts

(2006) Alex Luchin et al.   JOURNAL OF BONE AND MINERAL RESEARCH